1. Functional cardiac Na+ channels are expressed in human melanoma cells
- Author
-
Yali Cui, Samuel C. Dudley, Audrey Madigan, Alfredo Gonzalez, Benjamin Gallant, A. N. Xie, Hong Duo Chen, Han Guo, Matthew Clark, Yinsheng Wan, and Feng Feng
- Subjects
0301 basic medicine ,Membrane potential ,Cancer Research ,Depolarization ,Articles ,Cell biology ,03 medical and health sciences ,chemistry.chemical_compound ,Transient receptor potential channel ,030104 developmental biology ,0302 clinical medicine ,Oncology ,chemistry ,Apoptosis ,melanoma ,Tetrodotoxin ,Ultraviolet light ,Na+ channel ,membrane potential ,030217 neurology & neurosurgery ,Homeostasis ,Intracellular - Abstract
Resting membrane potential (RMP) and intracellular Ca2+ concentration [(Ca2+)i] are involved in tumorigenesis and metastasis. The present study investigated whether functional cardiac Na+ channels are expressed in human melanoma cells (WM 266-4) and its nonmalignant human melanocytes (HMC), as well as whether they participate in RMP maintenance and Ca2+ homeostasis. Confocal microscopy and western blot analysis were used to detect Na+ channels. The patch-clamp technique was employed to record Na+ currents and action potentials. Cytoplasmic Ca2+ was measured by loading Fluo-4. Cardiac (Nav1.5) Na+ channels were expressed in HMCs and WM 266-4 cells. Tetrodotoxin (TTX) dose-dependently blocked Na+ currents in WM 266-4 while HMCs had no Na+ currents. Ultraviolet light induced similar action potentials in HMCs and WM 266-4 cells, which were abolished by transient receptor potential A1 channel-specific blocker, HC-030031. Compared with HMCs, RMP was substantially depolarized in WM 266-4. TTX hyperpolarized RMP in WM 266-4 cells at a concentration of 30 µM, which facilitated Ca2+ influx. Compared with HMCs, (Ca2+)i was significantly higher in WM 266-4 cells and was elevated by 30 µM TTX. Collectively, Cardiac Na+ channels depolarize RMP and inhibit Ca2+ uptake in melanoma cells possibly contributing to tumorigenesis and metastasis. Na+ channel agonists may be developed to treat melanoma such as WM 266-4.
- Published
- 2018
- Full Text
- View/download PDF